Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Preferred Stock Liabilities (2020 - 2021)

PROCEPT BioRobotics (PRCT) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $328.6 million as the latest value for Q2 2021.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $328.6 million in Q2 2021 year-over-year; TTM through Jun 2021 was $328.6 million, a N/A change, with the full-year FY2020 number at $243.9 million, changed N/A from a year prior.
  • Preferred Stock Liabilities was $328.6 million for Q2 2021 at PROCEPT BioRobotics, up from $243.9 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $328.6 million in Q2 2021 to a low of $243.9 million in Q3 2020.